Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126641) titled 'Based on the apoptotic and pyroptotic cell phenotypes, this study explores the mechanism of chronic high intraocular pressure-induced damage to optic ganglion cells and the intervention effect of Qingguan II Formula' on June 12.
Study Type: Observational study
Study Design:
Factorial
Primary Sponsor: The First Hospital of Hunan University of Chinese Medicine
Condition:
PrimaryOpen-AngleGlaucoma
Intervention:
Primary Open-Angle Glaucoma (POAG) group:None
Recruitment Status: Recruiting
Phase: 0
Date of First Enrollment: 2025-09-05
Target Sample Size: Primary Open-Angle Glaucoma (POAG) group:60;Catarac...